METHOD FOR TREATING PATIENTS AT KAPOSI'S ECZEMA HERPETICUM AT DEVELOPING CONVERSION DISORDER Russian patent published in 2008 - IPC A61K31/573 A61K31/545 A61K31/502 A61K31/5513 A61K31/495 A61K31/407 A61K31/315 A61K31/522 A61K31/714 A61K31/713 A61K31/7105 A61K35/12 A61K38/21 A61K39/245 A61P17/02 A61P25/20 

FIELD: medicine.

SUBSTANCE: it is necessary to carry out complex medicinal therapy including specific antiviral preparations, group B-vitamins, immunocorrectors, injection of antiherpetic vaccine, and, also local therapy with derinate. Additionally, since the 1^st d of exacerbation it is important to inject flosteron once i/m at 1.0 ml, cefotaxym i/m twice daily per 1.0 mg for 10 d. Immunomodulator halavit on the 1^st d should be prescribed i/m at the dosage of 200 mg, and then for the next 15 d - twice daily per 100 mg i/m. Diazepam for 1 mo should be injected per 5.0 mg 4 times daily, and then per 2.5 mg 4 times daily for 1 mo, as well. One should daily inject atarax per 100 mg nocturnally for 1 mo and ketorol internally per 10 mg thrice daily for 10 d. Moreover, it is necessary to apply the composition out of 50.0 g zinc oxide, 5.0 ml ACD fraction and 25.0 g "Aciclovir" cream 4 times daily for 10 d. The innovation enables to considerably increase the efficiency of therapy due to improving the main immunological values, weakening local autoimmune reactions and, also, preventing the development of psychic disorders in such patients due to affecting viral neurotropic properties.

EFFECT: higher efficiency of therapy.

3 dwg, 1 ex